Verified earnings results
Aktis Oncology Q3 2026 Earnings Results
Direct answer
Aktis Oncology reported Q3 2026 results on November 12, 2026.
Revenue was 3,905,000. EPS missed the estimate by 9.71%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Aktis Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 12, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -0.4922
- Reported EPS
- -0.54
- Revenue
- 3,905,000
- EPS surprise
- EPS missed the estimate by 9.71%.
Explore related company data
Read the frequently asked questions.
When did Aktis Oncology report Q3 2026 earnings?
Aktis Oncology reported on November 12, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for Aktis Oncology?
The verified record provides an EPS estimate of -0.4922.
Has Aktis Oncology reported the Q3 2026 result?
Revenue was 3,905,000. EPS missed the estimate by 9.71%.
Which source supports this Aktis Oncology earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.